BCL2 and neoplasm: The average weights of tumors were 0.77 ± 0.12 gm and 2.24 ± 0.33 gm for experimental and control groups, respectively, and the rate of tumor growth with Bcl-2-siRNA treatment was 14.99% compared to 45.58% in the control group.